Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Human Therapeutics Pty. Ltd.

Latest From Human Therapeutics Pty. Ltd.

Caribou brings in $11m for CRISPR tech

Janssen touts Transposagen technology in CAR-T collaboration

Transposagen Biopharmaceuticals doesn't make a big public fuss about its pharmaceutical collaborations – the Lexington, Kentucky-based company has relationships with 19 out of the top 20 big pharma – but the Johnson & Johnson subsidiary Janssen Biotech is happy to tout the promise of its new partner's technology.

Cancer Neurology

BioNotebook: Three new deals, including Calico's first drug license agreement

Calico licenses UT Southwestern compounds from 2M; MabVax gets into CAR T business with MSKCC and Juno; and Kolltan buys Xetrios.

Cancer Neurology

Elan to 'release' $1bn from Tysabri pay-off

Elan will spend $1 billion of the $3.25 billion one-off payment it is receiving from Biogen Idec for the return of rights to the blockbuster multiple sclerosis drug Tysabri to buy back around a 16% stake in the Irish company.

Neurology Immune Disorders
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Australia
  • Parent & Subsidiaries
  • Human Therapeutics Pty. Ltd.
  • Senior Management
  • David Harrison, CEO
    Michael Egan, CFO
  • Contact Info
  • Human Therapeutics Pty. Ltd.
    Phone: (61) 299288800
    28 Barcoo St., East Roseville
    Sydney, 2069